UiPath Guides Q3 Revenue to $440-445M, Adds Kaiser Permanente Exec to Board
PATH sits 83% above its 52-week low of $9.2.
Summary
UiPath provided detailed FY2027 guidance: Q3 revenue of $440–445M, Q3 ARR of $1.992–1.997B, Q3 non-GAAP operating income of ~$100M, and full-year revenue of $1.789–1.794B with ARR of $2.065–2.070B. This follows yesterday's initial FY revenue guidance and adds quarterly granularity. The company also appointed Yazdi Bagli, EVP of IT and Enterprise Business Services at Kaiser Permanente, to its board, bringing enterprise IT leadership experience. The guidance suggests continued double-digit growth and profitability, reinforcing the positive trajectory from Q2 results. Watch for Q3 earnings to confirm execution against these targets.
At the time of this announcement, PATH was trading at $16.81 on NYSE in the Technology sector, with a market capitalization of approximately $9.4B. The 52-week trading range was $9.20 to $19.84. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.